相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
Padmanee Sharma et al.
CELL (2015)
Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia
Peter G. Maslak et al.
BLOOD (2010)
PR1-Specific T Cells Are Associated with Unmaintained Cytogenetic Remission of Chronic Myelogenous Leukemia After Interferon Withdrawal
Shreya Kanodia et al.
PLOS ONE (2010)
The Elusive Chronic Myeloid Leukemia Stem Cell: Does It Matter and How Do We Eliminate It?
Bing Z. Carter et al.
SEMINARS IN HEMATOLOGY (2010)
High avidity myeloid leukemia-associated antigen-specific CD8+ T cells preferentially reside in the bone marrow
J. Joseph Melenhorst et al.
BLOOD (2009)
A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS
Ulrich Keilholz et al.
BLOOD (2009)
A pilot vaccination trial of synthetic analog peptides derived from the BCR-ABL breakpoints in CML patients with minimal disease
P. G. Maslak et al.
LEUKEMIA (2008)
Hematopoietic stem cells and progenitors of chronic myeloid leukemia express leukemia-associated antigens: implications for the graft-versus-leukemia effect and peptide vaccine-based immunotherapy
A. S. M. Yong et al.
LEUKEMIA (2008)
Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies
Katayoun Rezvani et al.
BLOOD (2008)
Clinical evaluation of BCR-ABL peptide immunisation in chronic myeloid leukaemia: results of the EPIC study
J. M. Rojas et al.
LEUKEMIA (2007)
Modulation of graft-versus-host disease: Role of regulatory T lymphocytes
AD Hess
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Understanding the generation and function of memory T cell subsets
A Lanzavecchia et al.
CURRENT OPINION IN IMMUNOLOGY (2005)
A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia
K Cathcart et al.
BLOOD (2004)
Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression
Y Oka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-speciflic T cells
JJ Molldrem et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia
C Scheibenbogen et al.
BLOOD (2002)
New findings in pathogenesis of antineutrophil cytoplasm anti body-associated vasculitis
COS Savage et al.
CURRENT OPINION IN RHEUMATOLOGY (2002)
Dynamics of T lymphocyte responses: Intermediates, effectors, and memory cells
A Lanzavecchia et al.
SCIENCE (2000)
Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia
JJ Molldrem et al.
NATURE MEDICINE (2000)